These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34171540)

  • 1. The importance of viral and cellular factors on flavivirus entry.
    Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
    Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses.
    Carro SD; Cherry S
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33374822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactions of flaviviruses with cellular receptors: Implications for virus entry.
    Anwar MN; Akhtar R; Abid M; Khan SA; Rehman ZU; Tayyub M; Malik MI; Shahzad MK; Mubeen H; Qadir MS; Hameed M; Wahaab A; Li Z; Liu K; Li B; Qiu Y; Ma Z; Wei J
    Virology; 2022 Mar; 568():77-85. PubMed ID: 35149346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavivirus Receptors: Diversity, Identity, and Cell Entry.
    Laureti M; Narayanan D; Rodriguez-Andres J; Fazakerley JK; Kedzierski L
    Front Immunol; 2018; 9():2180. PubMed ID: 30319635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Targets for the Treatment of Flavivirus Infections.
    Zakaria MK; Carletti T; Marcello A
    Front Cell Infect Microbiol; 2018; 8():398. PubMed ID: 30483483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
    Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
    ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing the door on flaviviruses: entry as a target for antiviral drug design.
    Perera R; Khaliq M; Kuhn RJ
    Antiviral Res; 2008 Oct; 80(1):11-22. PubMed ID: 18585795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of ESCRT Proteins ALIX and CHMP4A and Their Interplay with Interferon-Stimulated Gene 15 during Tick-Borne Flavivirus Infection.
    Tran PT; Chiramel AI; Johansson M; Melik W
    J Virol; 2022 Feb; 96(3):e0162421. PubMed ID: 34851141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flaviviruses: braking the entering.
    Pierson TC; Kielian M
    Curr Opin Virol; 2013 Feb; 3(1):3-12. PubMed ID: 23352692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.
    Pierson TC; Diamond MS
    Expert Rev Mol Med; 2008 May; 10():e12. PubMed ID: 18471342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of flavivirus membrane fusion.
    Stiasny K; Fritz R; Pangerl K; Heinz FX
    Amino Acids; 2011 Nov; 41(5):1159-63. PubMed ID: 19882217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening.
    Dai S; Zhang Y; Zhang T; Zhang B; Wang H; Deng F
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29997331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.
    Zhang X; Jia R; Shen H; Wang M; Yin Z; Cheng A
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29137162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flavivirus capsid protein: Structure, function and perspectives towards drug design.
    Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC
    Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation.
    Campos RK; Wong B; Xie X; Lu YF; Shi PY; Pompon J; Garcia-Blanco MA; Bradrick SS
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5.
    Albentosa-González L; Jimenez de Oya N; Arias A; Clemente-Casares P; Martin-Acebes MÁ; Saiz JC; Sabariegos R; Mas A
    Viruses; 2021 May; 13(5):. PubMed ID: 34066055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RNA-binding proteins during the late stages of Flavivirus replication cycle.
    Diosa-Toro M; Prasanth KR; Bradrick SS; Garcia Blanco MA
    Virol J; 2020 Apr; 17(1):60. PubMed ID: 32334603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.